TYRO3 and thyroid gland carcinoma: Both AXL and TYRO3 are overexpressed in thyroid cancer cells and leiomyosarcoma cells, contributing to cell growth and resistance to apoptosis.208,209 Investigating the interplay between AXL and TYRO3 in cancer progression could offer insights into the varying responses of different cancer cells to AXL inhibitors.